Immunological aspects of schistosomiasis

Parasite Immunology

Volumn 27, Issue 7-8, 2005, Pages 243-246

  Mountford, Adrian P ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EDITORIAL; IMMUNE RESPONSE; IMMUNOLOGY; PARASITOSIS; PRIORITY JOURNAL; PUBLICATION; RESEARCH; SCHISTOSOMIASIS;

ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; HUMANS; MICE; SCHISTOSOMA; SCHISTOSOMIASIS;

EID: 25144447607     PISSN: 01419838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2005.00798.x     Document Type: Editorial

References (25)

1. Chitsulo L, Engels D, Montresor A & Savioli L. The global status of schistosomiasis and its control. Acta Trop 2000; 77: 41-51.
2. van der Werf MJ, de Vlas SJ, Brooker S, et al. Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop 2003; 86: 125-139.
3. Schistosomiasis. http://www.who.int/tdr/dw/schisto2004.htm.
4. King CH, Dickman K & Tisch DJ. Reassessment of the cost of chronic helminthic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 2005; 365: 1561-1569.
5. Cioli D & Pica-Mattoccia L. Praziquantel. Parasitol Res 2003; 90 (Suppl. 1): S3-S9.
6. Kourilova P, Hogg KG, Kolarova L & Mountford AP. Cercarial dermatitis caused by bird schistosomes comprises both immediate and late phase cutaneous hypersensitivity reactions. J Immunol 2004; 172: 3766-3774.
7. Dvorak J, Delcroix M, Rossi A, et al. Multiple cathepsin B isoforms in schistosomula of Trichobilharzia regenti: identification, characterisation and putative role in migration and nutrition. Int J Parasitol 2005; 35: 895-910.
8. van der Kleij D, Latz E, Brouwers JF, et al. A novel host-parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates toll-like receptor 2 and affects immune polarization. J Biol Chem 2002; 277: 48122-48129.
9. Van Liempt E, Imberty A, Bank CM, et al. Molecular basis of the differences in binding properties of the highly related C-type lectins DC-SIGN and L-SIGN to Lewis X trisaccharide and Schistosoma mansoni egg antigens. J Biol Chem 2004; 279: 33161-33167.
10. Thomas PG, Carter MR, Atochina O, et al. Maturation of dendritic cell 2 phenotype by a helminth glycan uses a Toll-like receptor 4-dependent mechanism. J Immunol 2003; 171: 5837-5841.
11. Wynn TA, Thompson RW, Cheever AW & Mentink-Kane MM. Immunopathogenesis of schistosomiasis. Immunol Rev 2004; 201: 156-167.
12. Stadecker MJ, Asahi H, Finger E, Hernandez HJ, Rutitzky LI & Sun J. The immunobiology of Th1 polarization in high-pathology schistosomiasis. Immunol Rev 2004; 201: 168-179.
13. Hesse M, Piccirillo CA, Belkaid Y, et al. The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells. J Immunol 2004; 172: 3157-3166.
14. + cells contribute to Th2 polarization during helminth infection by suppressing Th1 response development. J Immunol 2004; 173: 1224-1231.
15. Kane CM, Cervi L, Sun J, et al. Helminth antigens modulate TLR-initiated dendritic cell activation. J Immunol 2004; 173: 7454-7461.
16. Street M, Coulson PS, Sadler C, et al. TNF is essential for the cell-mediated protective immunity induced by the radiation-attenuated schistosome vaccine. J Immunol 1999; 163: 4489-4494.
17. + cells is a major feature of the innate immune response in mice that develop Th1-mediated protective immunity to Schistosoma mansoni. Infect Immun 2003; 71: 3563-3571.
18. Kariuki TM, Farah IO, Yole DS, et al. Parameters of the attenuated schistosome vaccine evaluated in the olive baboon. Infect Immun 2004; 72: 5526-5529.
19. Gabriel S, Phiri IK, Van Dam GJ, Decider AM, Duchateau L & Vercruysse J. Variations in the immune response to natural Schistosoma mattheei infections in calves born to infected mothers. Vet Parasitol 2004; 119: 177-185.
20. Hu W, Yan Q, Shen DK, et al. Evolutionary and biomedical implications of a Schistosoma japonicum complementary DNA resource. Nat Genet 2003; 35: 139-147.
21. Verjovski-Almeida S, DeMarco R, Martins EA, et al. Transcriptome analysis of the acoelomate human parasite Schistosoma mansoni. Nat Genet 2003; 35: 148-157.
22. Vennervald BJ & Dunne DW. Morbidity in schistosomiasis: an update. Curr Opin Infect Dis 2004; 17: 439-447.
23. Kouriba B, Chevillard C, Bream JH, et al. Analysis of the 5q31-q33 locus shows an association between IL13-1055C/T IL-13-591A/G polymorphisms and Schistosoma haematobium infections. J Immunol 2005; 174: 6274-6281.
24. Secor WE, Shah A, Mwinzi PM, Ndenga BA, Watta CO & Karanja DM. Increased density of human immunodeficiency virus type 1 coreceptors CCR5 and CXCR4 on the surfaces of CD4(+) T cells and monocytes of patients with Schistosoma mansoni infection. Infect Immun 2003; 71: 6668-6671.
25. Brown M, Mawa PA, Joseph S, et al. Treatment of Schistosoma mansoni infection increases helminth-specific type 2 cytokine responses and HIV-1 loads in coinfected Ugandan adults. J Inf Dis 2005; 191: 1648-1657.